Hormone Therapy & Side Effects For High-Risk (Gleason 8) #ProstateCancer | Mark Scholz, MD #PCRI

Hormone Therapy & Side Effects For High-Risk (Gleason 8) #ProstateCancer | Mark Scholz, MD #PCRIПодробнее

Intermediate-Risk: Do You Need Hormone Therapy With Radiation? | #MarkScholzMD #AlexScholz #PCRIПодробнее

Focal Therapy for #ProstateCancer: Lowest Risk of ED? | #MarkScholzMD #PCRI #AlexScholzПодробнее

3+4=7 #ProstateCancer | Active Surveillance vs. Focal Therapy | #MarkScholzMD #AlexScholz #PCRIПодробнее

Managing Gleason 4+4=8 #prostatecancer | #markscholzmd #pcriПодробнее

Advanced #ProstateCancer Treatments + Extended Q+A | #MarkScholzMD & #MarkMoyadMD #PCRIПодробнее

Treating Lymph Node Metastases #ProstateCancer | #MarkScholzMD | #AlexScholz #PCRIПодробнее

#ProstateCancer Diagnosis Over 80 Years Old | #MarkScholzMD #AlexScholz | #PCRIПодробнее

Gleason 9 & 10 Prostate Cancer: Cure Rates, Treatments, New Approaches | Mark Scholz, MD | PCRIПодробнее

Gleason 7 (4+3) #prostatecancer Treatments and Side Effects | #markscholzmd | PCRIПодробнее

Side Effects: Salvage Radiation, and Hormone Therapy | Mark Scholz, MD | PCRIПодробнее

High Risk Prostate Cancer: Surgery vs. Radiation | Genomic Tests | Mark Scholz, MD | PCRIПодробнее

New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

New FDA Approval: Darolutamide for Hormone-Sensitive Disease | Mark Scholz, MD | PCRIПодробнее

How PSMA Revolutionizes Staging for #prostatecancer | #markscholzmd | #PCRIПодробнее

Radiation and Hormone Therapy | Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

HIFU vs. TULSA PRO vs. Other Focal Therapies for Prostate Cancer | Mark Scholz, MD | PCRIПодробнее

How Radiation Affects The Prostate | Mark Scholz, MDПодробнее

New Study: Hormone Therapy & Heart Disease | Diet & Exercise | Mark Scholz, MD | PCRIПодробнее

A Medical Oncologist Compares Surgery and Radiation for Prostate Cancer | Mark Scholz, MD | PCRIПодробнее